Temu̲ ir bo̲ni 'nar 'Clear 'nar?
Ar me̲ti hingi lleva ar mutación. Hingi da nte ar enfermedad ne hinda thogi.
Mixi Gangliosidosis Gm2 In Japanese Domestic (GM2-JD)
Gangliosidosis GM2 in Japanese Domestic cats is a rare genetic disorder affecting the nervous system. This inherited condition leads to the accumulation of GM2 gangliosides, causing progressive neurological symptoms. A DNA test for Gangliosidosis GM2 helps breeders and cat owners identify carriers and affected cats early. Early diagnosis through genetic testing is crucial for managing the health and wellbeing of Japanese Domestic cats. By using a reliable DNA test, breeders can make informed decisions to prevent the spread of this debilitating disease. Protect your Japanese Domestic cat’s future with accurate Gangliosidosis GM2 DNA testing. Ensure a healthy lineage by screening for this genetic disorder today.
Abreviatura: GM2-JD
Mutación analizada: HEXB c.667C>T
Herencia: Autosómica recesiva
Acrónimo
GM2-JD
Frecuencia observada
Severidad clínica
Clasificación clínica
Metabolic Diseases
Mutación analizada
HEXB c.667C>T
p.(R223*)
p.(R223*)
Modo herencia
Autosómica recesiva
Resumen ar ntsa̲:
Gangliosidosis GM2 is a genetic disorder found in Japanese Domestic cats, caused by a deficiency in the enzyme responsible for breaking down GM2 gangliosides. A DNA test can identify carriers and affected cats by detecting mutations in the HEXA or HEXB genes. Early diagnosis through genetic testing helps breeders prevent the spread of this fatal disease. Affected cats typically show neurological symptoms such as weakness and loss of coordination. Responsible breeding practices rely on DNA testing to maintain the health of the Japanese Domestic cat population.
Disponible ndezu̲ ar pack: Basic
Nuna ar ntsa̲ ADN xi incluido a partir de ma pack Basic — ne 'nehe 'nar xe̲ni ja ya paquetes Basic, Standard, Advanced, Complete.
Ga paquetes ntsa̲ ADN →Da 'ñets'i ar paquete nä'ä mäs xi hño ar adapte ja ár estrategia ar reproducción wa nzaki yá me̲ti.
Understanding Gangliosidosis GM2 in Cats
Gangliosidosis GM2 is a genetic disorder that primarily affects the nervous system of cats. It is caused by a deficiency in the enzyme Hexosaminidase A (Hex-A), which is essential for the breakdown of certain lipids known as gangliosides. When this enzyme is deficient, gangliosides accumulate in the brain and other tissues, leading to progressive neurological dysfunction.
Clinical Signs of GM2 Gangliosidosis
Cats affected by GM2 gangliosidosis typically present a range of clinical signs that can vary in severity. Common symptoms include progressive weakness, lack of coordination, behavioral changes, and seizures. These symptoms usually manifest in young cats, often before they reach one year of age. As the condition progresses, affected cats may experience difficulty with movement, an inability to walk, and a decline in overall health.
Pathophysiology of GM2 Gangliosidosis
The pathophysiology of GM2 gangliosidosis is rooted in the accumulation of gangliosides due to the malfunction of the Hex-A enzyme. This accumulation leads to toxic effects on neuronal cells, resulting in cellular damage and death. Over time, the degeneration of nerve cells manifests as the neurological symptoms observed in affected cats. The condition is classified as a lysosomal storage disorder, highlighting the role of lysosomes in cellular waste management and the consequences of their dysfunction.
Genetic Basis of GM2 Gangliosidosis
GM2 gangliosidosis is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene—one from each parent—to develop the disease. The specific gene associated with this condition is located on chromosome 16 in cats. Genetic mutations that lead to the loss of Hex-A enzyme activity are responsible for the clinical manifestations of the disorder. Understanding the genetic foundation of GM2 gangliosidosis is critical for breeding programs aimed at reducing the incidence of this disease.
Diagnosis of GM2 Gangliosidosis
Diagnosis of GM2 gangliosidosis typically involves a combination of clinical evaluation and genetic testing. Veterinarians may suspect the condition based on clinical signs and a thorough neurological examination. However, definitive diagnosis often requires DNA testing to identify mutations in the gene responsible for the disorder. Early diagnosis is crucial for managing the condition and making informed decisions regarding the care of affected cats.
Management and Prognosis
Currently, there is no cure for GM2 gangliosidosis, and management focuses on supportive care to improve the quality of life for affected cats. This may include pain management, nutritional support, and environmental modifications to accommodate mobility challenges. The prognosis for cats with GM2 gangliosidosis is generally poor, with affected individuals often requiring humane euthanasia as the disease progresses. Awareness of this condition is essential for cat owners and breeders to make informed decisions regarding breeding practices and the health of their feline companions.
Ar raza reconocida pa ar ntsa̲: Gangliosidosis Gm2 In Japanese Domestic (GM2-JD)
- Japanese domestic
🧬 Interpretation of genotypes GM2-JD
Genotipo
Dätä
🟡 N/N
Hingi — portador — 'ñotho ar riesgo
🟡 N/GM2-JD
Carrier — 'ñotho ar riesgo
❌ GM2-JD/GM2-JD
Afectado — jar riesgo
FAQ: da 'yo̲de ar interpretación
¿Ge 'nar 'nar Carrier 'nar?
Hi'nä. Ar me̲ti ar nu'bu̲ da nthe̲hu̲ 'ra saludable pe tsa̲ da ungumfädi ar mutación ár descendencia.
¿Temu̲ thogi nu'bu̲ 'nar me̲ti 'nar afectado 'nar?
Lleva yoho ya kopya mutadas. Ya signos clínicos ar esperan dependiendo de ar enfermedad. Hingi da da criado.
¿Yogo'ä 'bu̲i ya hñäki ja ya macho yá femenino?
ra enfermedades gi 'bu̲hu̲ vinculadas ko ar nthä'mi, nä'ä ár hmä varía dependiendo de ar nt'ot'e ar me̲ti.
Predict descendencia
N/N (hingi-portador)
N/GM2-JD (Portador)
GM2-JD/GM2-JD (afectado)
Nt'a̲ni frecuentes test ADN
¿Temu̲ detecta nuna ntsa̲ ADN?
This DNA test detects the mutation associated with Gangliosidosis Gm2 In Japanese Domestic (GM2-JD) in order to identify clear, carrier, or at-risk animals.
¿Yogo'ä probar 'nar me̲ti reproductor?
Ntsa̲ ADN ayuda ja ya criadores planear apareamientos mäs seguros ne reducir riesgo ungumfädi ar mutación ja ar descendencia.
¿Teme ra modo herencia nuna ar ntsa̲?
Modo herencia reportado pa nuna ntsa̲ ar Autosómica recesiva.
¿Temu̲ ar mutación ar analiza jar nuna ntsa̲?
This test analyses the mutation HEXB c.667C>T.
¿'Bu̲i 'nar me̲ti portador necesariamente afectado?
Hingi nese. Interpretación bi jagu̲ju̲ hmu herencia ne ar genotipo resultante.
Referencias
Kanae Y, Endoh D, Yamato O, Hayashi D, Matsunaga S, Ogawa H, Maede Y, Hayashi M. Nonsense mutation of feline beta-hexosaminidase beta-subunit (HEXB) gene causing Sandhoff disease in a family of Japanese domestic cats. Res Vet Sci. 2007 Feb;82(1):54-60. doi: 10.1016/j.rvsc.2006.05.007. Epub 2006 Jul 26.